Epstein Secrets

avirus pandemic, but also to diseases like polio," because "for many countries that lack critical health infrastructure, the WHO functions as their Centers for Disease Control and Prevention." The Wall Street Journal (7/7, Al, Lubold, Subscription Publication, 7.57M), Newsweek (7/7, Roos, 1.53M), Townhall (7/7, McCarthy, 177K), and Brei

shown to be effective in clinical trials." CNN (7/7, Cohen, Bonifield, 83.16M) reports on its website that Novavax CEO/President Stanley Erck "said Novavax's vaccine could be on the market by the first quarter of next year." The Hill (7/7, Budryk, 2.98M) reports that "the award will also cover a large-

rnment To Pay $1.6B For Rush Vaccine Development. The CBS Evening NewsVi (7/7, story 3, 1:40, O'Donnell, 4.24M) reported, "Maryland biotech company Novavax is in the hunt for a coronavirus vaccine, and getting a major dose of funding from the government's Operation Warp Speed program." The New York lime

<https://www.washingtonpost.com/health/2020/07/21/coronavirus-states-data/> (7/21, Sun, I4.2M) reports that Resolve to Save Lives, headed by former Centers for Disease Control and Prevention Director Tom Frieden, released a report on Tuesday finding that "most states are failing to report critical information needed to track and control

video.bulletinintelligence.com/87d42052c6044d0c91e37241b21a638b? pubid=fbi> (7/21, story 5, 1:30, Holt, 6.23M) reported that "less than a week after Novavax, a Maryland biotech firm, announced that it was researching a potential COVID vaccine, the FBI says, a computer hacker in China, Li Xiaoyu, searche

nd passengers since the coronavirus pandemic began in March, with over 3 million people traveling in the past three days." The spike "comes despite Centers for Disease Control and Prevention guidance advising against Thanksgiving travel because of mounting covid-19 cases across the nation." Reuters (11/23, Trotta, Layne) reports, "Milli

ed by more than $10 billion in U.S taxpayer dollars. The government is also supporting an experimental vaccine from Sanofi/GSK and one from startup Novavax, which are expected to begin large trials in the U.S. in the coming weeks. Merck, which has received far less funding, is a few months further behin